Verseon Revenue

Pharmaceutical Manufacturing • Fremont, California, United States • 21-50 Employees

Verseon revenue & valuation

Annual revenue	$31,500,000
Revenue per employee	$1,310,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$100,600,000
Total funding	$11,800,000

Key Contacts at Verseon

Adityo Prakash

Ceo

David Kita

Vp Of R&D / Cofounder • Drug Discovery • Translational Research • Clinical Development

Company overview

Headquarters	47000-320 Warm Springs Blvd., Fremont, CA 94538, US
Phone number	+15102259000
Website	verseon.com
NAICS	3254
SIC	283
Founded	2002
Employees	21-50
Socials

Verseon Email Formats

Verseon uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	45.6%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	22.3%
{first name}@company.com	john@company.com	15.1%
{first name}{last name}@company.com	johndoe@company.com	9.8%
{first name}_{last name}@company.com	john_doe@company.com	7.2%

About Verseon

Verseon delivers pharmaceutical solutions using proprietary, computer-driven drug discovery platform technology. Through scientific advancements in physics- and chemistry-based modeling, Verseon’s gol is to address the cycle of slow and derivative pharmaceutical developments to create truly novel molecular entities. We innovate beyond the bounds of the known and design, test, and synthesize never-been-seen molecules that may soon become life-changing drugs. We began our mission in 2002 and since have built a proprietary platform that identifies novel potential therapeutics faster and more inexpensively than anyone in the industry. We are changing the way that drugs are made atom by atom. We are currently making great strides in cardiovascular diseases, macular degeneration, oncology, metabolic disorders, and mutation-resistant antivirals with over a dozen drug candidates in active development and one completing Phase 1 clinical trials.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Head

Employees by Department

Verseon has 14 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Verseon's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-10-16	14	$11,800,000

Funding Insights

$11,800,000

Total funding amount

$11,800,000

Most recent funding amount

Number of funding rounds

Verseon Tech Stack

Discover the technologies and tools that power Verseon's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Google Hosted Libraries

CDN

mod_wsgi

Web server extensions

jQuery

JavaScript libraries

OpenSSL

Web server extensions

GoDaddy

Hosting

CentOS

Operating systems

Google Tag Manager

Tag managers

PHP

Programming languages

Bootstrap

UI frameworks

Google Analytics

Analytics

jsDelivr

CDN

Frequently asked questions

Verseon is located in Fremont, California, US.

You can reach Verseon at +15102259000.

Verseon generates an estimated annual revenue of $31,416,363. This revenue figure reflects the company's market position and business performance in its industry.

Verseon has an estimated valuation of $100,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Verseon was founded in 2002, making it 24 years old. The company has established itself as a significant player in its industry over this time.

Verseon has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Verseon has raised a total of $11,800,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Verseon

Adityo Prakash

Ceo

David Kita

Vp Of R&D / Cofounder • Drug Discovery • Translational Research • Clinical Development

4.8

40,000 users